Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2651

Actual shortage: 257 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2385 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2021-02-11 2021-03-11 133779
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-04-21 2021-07-29 137885
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-09-02 2021-12-02 145106
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2021-09-30 2021-10-21 146437
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2022-01-13 2022-02-17 152685
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-02-17 2023-02-09 155140
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-04-21 2022-10-29 159186
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2022-09-30 2022-10-18 170776
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-12 2023-11-23 198391
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-10-05 2024-01-25 206431
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-18 215751
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2017-04-03 2019-01-03 5189
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2017-04-03 2019-01-03 5192
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-10-03 2019-10-10 95370
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2022-09-07 2023-10-05 168733
TEVA-DUTASTERIDE 0.5MG CAPSULE Actual shortage 2023-02-09 2024-04-11 184216
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2023-06-16 2023-07-05 195164
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2023-06-20 2023-07-05 195775
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2023-10-19 2024-04-11 207548
TEVA-ECTOSONE 0.1% CREAM Resolved 2020-03-19 2020-07-09 109053

Showing 1141 to 1160 of 2651

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 61 to 80 of 250